December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ziopharm Oncology IN (NQ: ZIOP )

3.600 USD -0.160 (-4.26%)
Streaming Delayed Price Updated: 4:17 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Ziopharm Oncology IN

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Ziopharm Oncology Announces Election of James Huang as Chairman of the Board of Directors
From GlobeNewswire News Releases
Ziopharm to Participate in Upcoming January Conferences
From GlobeNewswire News Releases
Ziopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
From GlobeNewswire News Releases
WaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), a sizable and long-term shareholder of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”), today... 
From Business Wire News Releases
Ziopharm Comments on Consent Solicitation Results
Jaime Vieser and Holger Weis Elected to Board of Directors 
From GlobeNewswire News Releases
Ziopharm Oncology Announces Chief Financial Officer to Step Down
From GlobeNewswire News Releases
WaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent Threat
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. (NASDAQ: ZIOP)... 
From Business Wire News Releases
Ziopharm Comments on Delay of WaterMill’s Stated Consent Deadline
From GlobeNewswire News Releases
Egan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm Board
From GlobeNewswire News Releases
WaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm Oncology
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Ziopharm Details Actions in Response to Shareholder Feedback
From GlobeNewswire News Releases
Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and Proposals
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading proxy advisory firm, has endorsed its case... 
From Business Wire News Releases
WaterMill Asset Management Refutes Ziopharm Oncology’s Desperate, Low-Road Smear Campaign
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Ziopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of Directors
From GlobeNewswire News Releases
ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
WaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders and Rewrite History
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value
From GlobeNewswire News Releases
WaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
White Rock Capital Supports WaterMill's Case for Change at Ziopharm Oncology
White Rock Capital Partners, L.P. ("White Rock Capital"), along with all of its related entities, will vote 100% of its approximately 6.1 million common shares (which excludes 3.8 million warrants) of... 
From PR Newswire
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2020 Society for Neuro-Oncology Annual Meeting
From GlobeNewswire News Releases
Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer
From GlobeNewswire News Releases
Ziopharm Oncology Appoints Mary Thistle to Board of Directors
From GlobeNewswire News Releases
Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020
From GlobeNewswire News Releases
Level One Partners Supports Watermill’s Proposal for Ziopharm Oncology
Level One Partners, LLC, (“Level One Partners”) along with all of its related entities, will vote 100% of its approximately 10.68 million shares of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or... 
From Business Wire News Releases
WaterMill Asset Management Releases Candid Q&As with Each of its Director Candidates for Election to Ziopharm Oncology’s Board
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Discovery Capital Management Will Vote For All of WaterMill’s Stated Proposals at Ziopharm Oncology
Discovery Capital Management, LLC (collectively with its affiliated entities, “Discovery” or “we”) today announced that it will vote 100% of its more than 10.6 million shares of Ziopharm Oncology, Inc.... 
From Business Wire News Releases
Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders
From GlobeNewswire News Releases
WaterMill Asset Management Launches Consent Solicitation to Reconstitute the Board of Directors of Ziopharm Oncology
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.